Advertisement
Abstract| Volume 45, SUPPLEMENT 2, S47, November 2022

Does metastases-direct therapy guided by PSMA PET/CT really improve oncologic outcomes in oligorecurrent prostate cancer patients?

      This paper is only available as a PDF. To read, Please Download here.